News
-
-
-
REGULATED PRESS RELEASE
Announcement of share buyback in the context of a share purchase plan for its personnel
Gimv announces start of share buyback program under share purchase plan for employees, buying 30,000 shares on Euronext Brussels from Feb 21 to Mar 15, 2024. Program conducted as per regulations -
REGULATED PRESS RELEASE
Aankondiging inkoop eigen aandelen in het kader van een aandelenaankoopplan voor het personeel
Gimv start inkoopprogramma eigen aandelen voor personeel in het kader van aandelenaankoopplan. Uitvoering via Euronext Brussel met onafhankelijke broker. Inkoop loopt tot 15 maart 2024 -
REGULATED PRESS RELEASE
Gimv neemt als co-leadinvesteerder deel aan een Series C financieringsronde van 30 miljoen EUR bij Onera Health.
Gimv neemt deel aan Series C financieringsronde van 30 miljoen EUR bij Onera Health, een pionier in slaapdiagnostiek en monitoring op afstand. Financiering stelt Onera Health in staat om productie en verkoop te versnellen en de ambitie te worden in hPSG binnen slaapgeneeskunde -
-
REGULATED PRESS RELEASE
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
Onera Health announces completion of a €30M Series C financing round led by EQT Life Sciences and co-led by Gimv, aiming to accelerate manufacturing and sales of its innovative sleep testing solutions and become the leader in hPSG. GIMV, Series C financing, Onera Health, sleep medicine, remote sleep diagnostic, PSG system -
REGULATED PRESS RELEASE
Gimv acts as co-lead investor in a €30M Series C financing round at Onera Health
Onera Health, a leader in remote sleep diagnostic and monitoring solutions, has announced the successful completion of a €30M Series C financing round, co-led by Gimv and EQT Life Sciences. This funding will enable Onera Health to accelerate manufacturing and sales to meet growing customer demand for its innovative sleep testing solutions. The company aims to become the leader in home PSG (hPSG) within the field of sleep medicine by bringing clinical-grade PSG diagnostics and monitoring directly to the patient’s bed. This press release highlights the significant impact and potential of Onera Health's innovative technology in disrupting the sleep testing market. -
REGULATED PRESS RELEASE
Gimv invests in Castelein Sealants to accelerate European growth
-
REGULATED PRESS RELEASE
Gimv invests in Castelein Sealants to accelerate European growth
